Cancers, infections, and endocrine diseases in women with endometriosis.

[1]  A. Valachis,et al.  Mononucleosis and Epstein-Barr virus infection: treatment and medication , 2012 .

[2]  黄亚明 eMedicine , 2009 .

[3]  K. Osteen,et al.  Dioxin may promote inflammation-related development of endometriosis. , 2008, Fertility and sterility.

[4]  P. Sparén,et al.  The risk of cancer and the role of parity among women with endometriosis. , 2007, Human reproduction.

[5]  F. Clavel-Chapelon,et al.  Personal history of endometriosis and risk of cutaneous melanoma in a large prospective cohort of French women. , 2007, Archives of internal medicine.

[6]  S. Cleary,et al.  Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience. , 2007, Fertility and sterility.

[7]  P. Sparén,et al.  Endometriosis and the risk of cancer with special emphasis on ovarian cancer. , 2006, Human reproduction.

[8]  L. Brinton,et al.  Causes of Infertility as Predictors of Subsequent Cancer Risk , 2005, Epidemiology.

[9]  D. Gertig,et al.  Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[10]  P. Post,et al.  Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies , 2004, Acta obstetricia et gynecologica Scandinavica.

[11]  M. Goodman,et al.  Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. , 2004, American journal of obstetrics and gynecology.

[12]  L. Brinton,et al.  Ovarian cancer risk associated with varying causes of infertility. , 2004, Fertility and sterility.

[13]  H. Steed,et al.  Endometriosis-associated ovarian cancer: a clinicopathologic review. , 2004, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[14]  C. Borgfeldt,et al.  Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. , 2004, Acta obstetricia et gynecologica Scandinavica.

[15]  M. Goodman,et al.  Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  L. Larocca,et al.  Possible involvement of hMLH1, p16INK4a and PTEN in the malignant transformation of endometriosis , 2002, International journal of cancer.

[17]  L. Nieman,et al.  High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. , 2002, Human reproduction.

[18]  D. Brogan,et al.  Breast cancer risk in young women and history of selected medical conditions. , 1999, International journal of epidemiology.

[19]  G. Chenevix-Trench,et al.  Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. , 1998, Cancer research.

[20]  M. Canis,et al.  Glutathione S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population. , 1997, Molecular human reproduction.

[21]  B. Gillespie,et al.  The epidemiology of vulvovaginal candidiasis among university students. , 1995, American journal of public health.

[22]  B. Pasternack,et al.  The influence of medical conditions associated with hormones on the risk of breast cancer. , 1993, International journal of epidemiology.

[23]  D. Savage,et al.  Prevalence and clinical features of mitral valve prolapse. , 1987, American heart journal.

[24]  Parsons Vl,et al.  Current estimates from the National Health Interview Survey. United States, 1985. , 1986, Vital and health statistics. Series 10, Data from the National Health Survey.

[25]  L. Brinton,et al.  Cancer risk after a hospital discharge diagnosis of endometriosis , 2011 .

[26]  E. Thomas,et al.  GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer. , 2001, Carcinogenesis.

[27]  A. Sober,et al.  Association between endometriosis, dysplastic naevi and history of melanoma in women of reproductive age. , 1997, Human reproduction.